Table 3.
Kinetics of replication, cytokine release and clinical manifestations of infections with hPIV serotypes 1–3 according to Schaap-Nutt et al. [16•]
Serotype | Locus of replication | Kinetics of replication | Released cytokine upon infection | Clinical manifestations | Remarks |
---|---|---|---|---|---|
hPIV-1 | Upper respiratory tract | Replicates to high titres and does not induce cytokine secretion until late in infection | RANTES IP-10 I-TAC | Upper respiratory tract illnesses, croup | Undetected for several days post infection |
hPIV-2 | Upper respiratory tract | Replicates less efficiently than hPIV-1 but induces an early cytokine peak | IFN-α IL-6MCP-1 RANTES IP-10 I-TAC | Upper respiratory tract illnesses, croup | Less able to inhibit an early immune response |
hPIV-3 | Lower respiratory tract | Replicates to high titres but induces a slower increase in cytokine secretion | IFN-α IL-6 MCP-1 RANTES IP-10 I-TAC | Bronchiolitis, pneumonia | Induces a steadily increasing inflammatory response over several days |